Medtronic Q3 in focus amid MedTech’s post-COVID gains

admin

Medtronic Q3 in focus amid MedTech’s post-COVID gains


Bloomberg/Bloomberg via Getty Images

Medtronic (NYSE:MDT) is scheduled to report its Q3 FY24 results on Tuesday before the opening bell, with investors expecting another strong quarter from the Dublin, Ireland-based medical device maker as MedTech’s post-pandemic recovery continues.

With their latest financials, MDT’s peers haveJNJBSXSYKABT

SOURCE

Leave a Comment